Swiss venture capital investor Redalpine has closed its eighth fund at $250 million. Redalpine Capital VIII reached its hard ...

Germany-based biotech company SRTD Biotech has closed a €31.5 million seed funding round. At the heart of its approach is an ...

British biotech Neobe Therapeutics has raised $6.8 million (€6.1 million) in seed funding to develop engineered bacteria that ...

Dutch-Belgian immunology company argenx has agreed to acquire California-based Unnatural Products Inc. (UNP) for up to $1.15 ...

U.K. biotech Immunocore has reported an estimated 70% two-year survival rate among 17 evaluable first-line metastatic uveal ...

Gene therapies began as proof-of-concept treatments for a handful of rare genetic disorders and now, with emerging tools, may ...

University of Oxford spinout Alethio Therapeutics has raised $90 million (about €80 million) to take its G6B-targeting ...

The Mainz-based vaccine developer is making progress in its transformation into an oncology company. But its quarterly report ...

Nine reports of tumors in children treated with Novartis' spinal muscular atrophy (SMA) gene therapy Zolgensma raise new ...

French pharmaceutical group Servier has suffered a major setback just four months after completing its $1.55 billion upfront ...

Boehringer is turning to China for cancer research in a multibillion-dollar deal with Sino Biopharmaceutical. Six preclinical ...

Dutch biotech Anaheim Bio, a spin-out of BioMarin-acquired Alesta Therapeutics, has launched with an oversubscribed €40 ...